Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer

Implications for chemotherapy

Tsang Pai Liu, Chi Chou Huang, Ken Tu Yeh, Tao Wei Ke, Po Li Wei, Ji Rui Yang, Ya Wen Cheng

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Colorectal cancer (CRC) guidelines recommend adjuvant chemotherapy according to the level of lymph node metastasis. Let-7a-5p is a microRNA, which inhibits migration, invasion, as well as the epithelial-mesenchymal transition by targeting HMGA2. The aim of this study was to investigate the role of let-7a-5p in the clinical impact of CRC. In this study, one hundred and ninety-two CRC patients were enrolled. The expression of let-7a-5p and HMGA2 in serum and tumour tissues were analysed by real-time PCR and immunohistochemistry. Kaplan-Meier analysis was used to analyse primary outcomes, including the survival and tumour recurrence. The expression of let-7a-5p in tumour tissues was significantly negative correlated with the tumour size, stage and lymph node metastasis in CRC patients (p = 0.024 for tumour size, p < 0.0001 for stage and p < 0.0001 for lymph node metastasis). There was a negative correlation between the levels of let-7a-5p and the HMGA2 protein (p < 0.0001). The overall survival (OS) and disease-free survival (DFS) rates of patients with let-7a-5p low/. HMGA2 high were poorer than those with let-7a-5p high/. HMGA2 high, let-7a-5p high/HMGA2 low and let-7a-5p low/. HMGA2 low. In addition, the expression levels of let-7a-5p in serums were positively correlated with let-7a-5p in the tumour tissues of the CRC patients. The expression levels of let-7a-5p in serums also could be used as a biomarker to predict clinical outcome. We suggest that down-regulation of let-7a-5p in serums and tumour tissues of CRC patients could be used to predict lymph node metastasis and the disease prognosis. These results could be implicated for chemotherapy suggestion.

Original languageEnglish
Pages (from-to)429-434
JournalSurgical Oncology
Volume25
Issue number4
DOIs
Publication statusPublished - Dec 1 2016

Fingerprint

Colorectal Neoplasms
Down-Regulation
Lymph Nodes
Neoplasm Metastasis
Drug Therapy
Neoplasms
Serum
HMGA2 Protein
Epithelial-Mesenchymal Transition
Survival
Kaplan-Meier Estimate
Adjuvant Chemotherapy
MicroRNAs
Disease-Free Survival
Real-Time Polymerase Chain Reaction
Survival Rate
Biomarkers
Immunohistochemistry
Guidelines
Recurrence

Keywords

  • Colorectal cancer
  • HMGA2
  • Let-7a-5p
  • Metastasis
  • MiR-21

ASJC Scopus subject areas

  • Oncology
  • Surgery

Cite this

Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer : Implications for chemotherapy. / Liu, Tsang Pai; Huang, Chi Chou; Yeh, Ken Tu; Ke, Tao Wei; Wei, Po Li; Yang, Ji Rui; Cheng, Ya Wen.

In: Surgical Oncology, Vol. 25, No. 4, 01.12.2016, p. 429-434.

Research output: Contribution to journalArticle

Liu, Tsang Pai ; Huang, Chi Chou ; Yeh, Ken Tu ; Ke, Tao Wei ; Wei, Po Li ; Yang, Ji Rui ; Cheng, Ya Wen. / Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer : Implications for chemotherapy. In: Surgical Oncology. 2016 ; Vol. 25, No. 4. pp. 429-434.
@article{157ba1624bf24f23999ee5af63557719,
title = "Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy",
abstract = "Colorectal cancer (CRC) guidelines recommend adjuvant chemotherapy according to the level of lymph node metastasis. Let-7a-5p is a microRNA, which inhibits migration, invasion, as well as the epithelial-mesenchymal transition by targeting HMGA2. The aim of this study was to investigate the role of let-7a-5p in the clinical impact of CRC. In this study, one hundred and ninety-two CRC patients were enrolled. The expression of let-7a-5p and HMGA2 in serum and tumour tissues were analysed by real-time PCR and immunohistochemistry. Kaplan-Meier analysis was used to analyse primary outcomes, including the survival and tumour recurrence. The expression of let-7a-5p in tumour tissues was significantly negative correlated with the tumour size, stage and lymph node metastasis in CRC patients (p = 0.024 for tumour size, p < 0.0001 for stage and p < 0.0001 for lymph node metastasis). There was a negative correlation between the levels of let-7a-5p and the HMGA2 protein (p < 0.0001). The overall survival (OS) and disease-free survival (DFS) rates of patients with let-7a-5p low/. HMGA2 high were poorer than those with let-7a-5p high/. HMGA2 high, let-7a-5p high/HMGA2 low and let-7a-5p low/. HMGA2 low. In addition, the expression levels of let-7a-5p in serums were positively correlated with let-7a-5p in the tumour tissues of the CRC patients. The expression levels of let-7a-5p in serums also could be used as a biomarker to predict clinical outcome. We suggest that down-regulation of let-7a-5p in serums and tumour tissues of CRC patients could be used to predict lymph node metastasis and the disease prognosis. These results could be implicated for chemotherapy suggestion.",
keywords = "Colorectal cancer, HMGA2, Let-7a-5p, Metastasis, MiR-21",
author = "Liu, {Tsang Pai} and Huang, {Chi Chou} and Yeh, {Ken Tu} and Ke, {Tao Wei} and Wei, {Po Li} and Yang, {Ji Rui} and Cheng, {Ya Wen}",
year = "2016",
month = "12",
day = "1",
doi = "10.1016/j.suronc.2016.05.016",
language = "English",
volume = "25",
pages = "429--434",
journal = "Surgical Oncology",
issn = "0960-7404",
publisher = "Elsevier BV",
number = "4",

}

TY - JOUR

T1 - Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer

T2 - Implications for chemotherapy

AU - Liu, Tsang Pai

AU - Huang, Chi Chou

AU - Yeh, Ken Tu

AU - Ke, Tao Wei

AU - Wei, Po Li

AU - Yang, Ji Rui

AU - Cheng, Ya Wen

PY - 2016/12/1

Y1 - 2016/12/1

N2 - Colorectal cancer (CRC) guidelines recommend adjuvant chemotherapy according to the level of lymph node metastasis. Let-7a-5p is a microRNA, which inhibits migration, invasion, as well as the epithelial-mesenchymal transition by targeting HMGA2. The aim of this study was to investigate the role of let-7a-5p in the clinical impact of CRC. In this study, one hundred and ninety-two CRC patients were enrolled. The expression of let-7a-5p and HMGA2 in serum and tumour tissues were analysed by real-time PCR and immunohistochemistry. Kaplan-Meier analysis was used to analyse primary outcomes, including the survival and tumour recurrence. The expression of let-7a-5p in tumour tissues was significantly negative correlated with the tumour size, stage and lymph node metastasis in CRC patients (p = 0.024 for tumour size, p < 0.0001 for stage and p < 0.0001 for lymph node metastasis). There was a negative correlation between the levels of let-7a-5p and the HMGA2 protein (p < 0.0001). The overall survival (OS) and disease-free survival (DFS) rates of patients with let-7a-5p low/. HMGA2 high were poorer than those with let-7a-5p high/. HMGA2 high, let-7a-5p high/HMGA2 low and let-7a-5p low/. HMGA2 low. In addition, the expression levels of let-7a-5p in serums were positively correlated with let-7a-5p in the tumour tissues of the CRC patients. The expression levels of let-7a-5p in serums also could be used as a biomarker to predict clinical outcome. We suggest that down-regulation of let-7a-5p in serums and tumour tissues of CRC patients could be used to predict lymph node metastasis and the disease prognosis. These results could be implicated for chemotherapy suggestion.

AB - Colorectal cancer (CRC) guidelines recommend adjuvant chemotherapy according to the level of lymph node metastasis. Let-7a-5p is a microRNA, which inhibits migration, invasion, as well as the epithelial-mesenchymal transition by targeting HMGA2. The aim of this study was to investigate the role of let-7a-5p in the clinical impact of CRC. In this study, one hundred and ninety-two CRC patients were enrolled. The expression of let-7a-5p and HMGA2 in serum and tumour tissues were analysed by real-time PCR and immunohistochemistry. Kaplan-Meier analysis was used to analyse primary outcomes, including the survival and tumour recurrence. The expression of let-7a-5p in tumour tissues was significantly negative correlated with the tumour size, stage and lymph node metastasis in CRC patients (p = 0.024 for tumour size, p < 0.0001 for stage and p < 0.0001 for lymph node metastasis). There was a negative correlation between the levels of let-7a-5p and the HMGA2 protein (p < 0.0001). The overall survival (OS) and disease-free survival (DFS) rates of patients with let-7a-5p low/. HMGA2 high were poorer than those with let-7a-5p high/. HMGA2 high, let-7a-5p high/HMGA2 low and let-7a-5p low/. HMGA2 low. In addition, the expression levels of let-7a-5p in serums were positively correlated with let-7a-5p in the tumour tissues of the CRC patients. The expression levels of let-7a-5p in serums also could be used as a biomarker to predict clinical outcome. We suggest that down-regulation of let-7a-5p in serums and tumour tissues of CRC patients could be used to predict lymph node metastasis and the disease prognosis. These results could be implicated for chemotherapy suggestion.

KW - Colorectal cancer

KW - HMGA2

KW - Let-7a-5p

KW - Metastasis

KW - MiR-21

UR - http://www.scopus.com/inward/record.url?scp=84973900779&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84973900779&partnerID=8YFLogxK

U2 - 10.1016/j.suronc.2016.05.016

DO - 10.1016/j.suronc.2016.05.016

M3 - Article

VL - 25

SP - 429

EP - 434

JO - Surgical Oncology

JF - Surgical Oncology

SN - 0960-7404

IS - 4

ER -